2-Chloroadenosine

We are 2-Chloroadenosine CAS:146-77-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloroadenosine
CAS.NO:146-77-0
Synonyms:6-Amino-2-chloropurine riboside
6-Amino-2-chloropurine Riboside Hydrate
6-Amino-2-chloro-9-(β-D-ribofuranosyl)purine Hydrate
Adenosine, 2-chloro-
2-CADO Hydrate
Molecular Formula:C10H12ClN5O4
Molecular Weight:301.68600
 
Physical and Chemical Properties:
Density:2.19
Melting point:162ºC
Boiling point:591.8ºC
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
Loss on drying:≤1.0%
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Regadenoson

2-Chloroadenosine


Related News: ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide CAS:356068-86-5 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.4-(1-phenylethyl)benzene-1,3-diol This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.2-Ethyl-3-methoxypyrazine CAS:25680-58-4 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.

Related Products
Product Name
3-(Trifluoromethyl)benzyl bromide View Details
picolinic acid View Details
2-(7-methoxynaphthalen-1-yl)ethanamine,hydrochloride View Details
4-Chloro-2-fluorobenzaldehyde manufacturer 6-bromohexanoic acid manufacturer 1-bromodibenzo[b,d]furan manufacturer 4,4,5,5-tetramethyl-2-(3-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane manufacturer 5-Fluoro-2-methylbenzoic acid manufacturer